OB Cadherin anticorps

N° du produit ABIN335403

Détail du produit anti-OB Cadherin anticorps

Antigène: OB Cadherin (CDH11) (Cadherin 11 (CDH11))

Reactivité: Humain, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp OB Cadherin est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunocytochemistry (ICC)

Specificité: Human and rat.

Purification: Protein A affinity column

Immunogène: 16A is a mouse monoclonal IgG1 antibody obtained by fusion of SP2/0 mouse myeloma cells with spleen cells from a mouse immunized with affinity purified extracellular domain of human cadherin-11-GST fusion protein.

Clone: 16A

Isotype: IgG1

Information d'application

Indications d'application: 16A recognizes the extracellular domain of cadherin-11. 16A is suitable for immunoblotting, immunocytochemistry and immunohistochemistry on frozen sections when using a PBS buffer containing 0.1 mM CaCl 2 and 0.1 mM MgCl 2 . Optimal antibody dilution should be determined by titration, recommended range is 1:25 - 1:50 for immunohistochemistry with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent, and 1:25 - 1:250 for immunoblotting applications.

Restrictions: For Research Use only

Stockage

Stock: 4 °C

Références pour anticorps anti-OB Cadherin (ABIN335403)

Tomita, van Bokhoven, van Leenders, Ruijter, Jansen, Bussemakers, Schalken: "Cadherin switching in human prostate cancer progression." dans: Cancer research, Vol. 60, Issue 13, pp. 3650-4, (2000) (PubMed).

Bussemakers, Van Bokhoven, Tomita, Jansen, Schalken: "Complex cadherin expression in human prostate cancer cells." dans: International journal of cancer. Journal international du cancer, Vol. 85, Issue 3, pp. 446-50, (2000) (PubMed).

Détails sur OB Cadherin

Antigène: OB Cadherin (CDH11) (Cadherin 11 (CDH11))

Autre désignation: OB-Cadherin / Cadherin-11 (CDH11 Produits)

Synonymes: anticorps cad11, anticorps cdhob, anticorps osf-4, anticorps Xcad-11, anticorps MGC108014, anticorps OB-cadherin, anticorps cadherin-11, anticorps Cad11, anticorps cdhvn, anticorps vnc, anticorps CAD11, anticorps CDHOB, anticorps OB, anticorps OSF-4, anticorps cadherin 11, anticorps cadherin 11, type 2, OB-cadherin (osteoblast), anticorps cadherin 11 S homeolog, anticorps CDH11, anticorps cdh11, anticorps Cdh11, anticorps cdh11.S

Sujet: Cadherins constitute a family of transmembrane glycoproteins involved in Ca 2+ -dependent cell-cell interactions. The members of this family are differentially expressed in various tissues. They function in the maintenance of tissue integrity and morphogenesis. The cadherins generally contain five extracellular repeats, a transmembrane domain and a cytoplasmic tail that binds to the catenin family of cytoskeletal anchoring proteins which also function as signal transducers. The extracellular domains are responsible for the specificity of homophilic interactions between cells expressing the same cadherin. Cadherins are divided into type I and type II subgroups. Type I cadherins include epithelial cadherin (E-cadherin, cadherin-1 or uvomorulin), neural cadherin (N-cadherin or cadherin-2), placental cadherin (P-cadherin or cadherin-3) and retinal cadherin (R-cadherin or cadherin-4). Kidney cadherin (K-cadherin or cadherin-6) and osteoblast cadherin (OB-cadherin or cadherin-11) are type II cadherins. The progression of carcinomas is associated with the loss of epithelial morphology and a concomitant acquisition of a more mesenchymal phenotype, which is thought to contribute to the invasive and/or metastatic behavior. A putative role for cadherin-11 in these late stages of tumor progression is based on the fact that migration of mesenchymal cells is facilitated when cadherin-11 is highly expressed.